Skip to content

Clinical trials

Colonic Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Country / region: Hong Kong Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20092
20101
20174
20181
20203
20211
20222
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Unknown status4
Recruiting3
Approved for marketing1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
Eli Lilly and Company3
The University of Hong Kong3
Novartis Pharmaceuticals2
Amgen1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
NantCell, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms22
Colorectal Neoplasms7
Rectal Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Colonic Polyps5
Head and Neck Neoplasms4
Lung Neoplasms4
Neoplasms4
Thyroid Neoplasms4
Adenocarcinoma3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.